Scarica l'app Stockscreener
19.51
1.14%
0.22
Dopo l'orario di chiusura:
19.51
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$19.29
Aprire:
$18.83
Volume 24 ore:
209.44K
Relative Volume:
0.52
Capitalizzazione di mercato:
$942.33M
Reddito:
$96.21M
Utile/perdita netta:
$-12.13M
Rapporto P/E:
-62.33
EPS:
-0.313
Flusso di cassa netto:
$10.64M
1 W Prestazione:
-0.71%
1M Prestazione:
-13.37%
6M Prestazione:
-24.70%
1 anno Prestazione:
-17.96%
Intervallo 1D:
$18.78
$19.60
Intervallo di 1 settimana:
$17.89
$19.60
Portata 52W:
$17.86
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Nome
Biolife Solutions Inc
Settore
Industria
Telefono
(425) 401-1400
Indirizzo
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
19.51 | 942.33M | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
452.07 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.56 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.28 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.09 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2024-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-11 | Iniziato | Craig Hallum | Buy |
| 2022-04-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Iniziato | B. Riley Securities | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-05-14 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Iniziato | Cowen | Outperform |
| 2020-08-11 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Reiterato | Maxim Group | Buy |
| 2020-02-24 | Iniziato | Lake Street | Buy |
| 2020-02-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Ripresa | B. Riley FBR | Buy |
| 2020-01-08 | Iniziato | Stephens | Overweight |
| 2019-11-21 | Iniziato | Oppenheimer | Outperform |
| 2019-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Reiterato | Maxim Group | Buy |
| 2017-09-19 | Reiterato | Maxim Group | Buy |
| 2017-07-05 | Aggiornamento | Janney | Neutral → Buy |
| 2017-03-10 | Reiterato | Maxim Group | Buy |
| 2017-01-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Biolife Solutions Inc Borsa (BLFS) Ultime notizie
BLFS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Virtual Meeting for BioLife Solutions (BLFS) Scheduled for April 8 - GuruFocus
Smart Money: What are analysts price targets for BioLife Solutions Inc2026 Final Week & Precise Buy Zone Identification - baoquankhu1.vn
Foster Karen A., chief quality and operations, sells BioLife Solutions (BLFS) shares for $49k - Investing.com
BioLife Solutions (BLFS) executive sells 2,577 shares under 10b5-1 plan - Stock Titan
BioLife Solutions, Inc. (BLFS) Stock forecasts - Yahoo Finance UK
BioLife Solutions Inc (BLFS) Stock Price Quote Today & Current Price Chart - Capital.com
Stock Analysis: What are analysts price targets for BioLife Solutions IncDay Trade & Smart Investment Allocation Insights - baoquankhu1.vn
BioLife Solutions (NASDAQ:BLFS) Stock Passes Below 200 Day Moving AverageShould You Sell? - MarketBeat
Vanguard (BLFS) Amendment shows 0 shares and 0% after Jan 12, 2026 realignment - Stock Titan
Dividend Watch: Does BioLife Solutions Inc offer margin of safetyMarket Weekly Review & Daily Entry Point Trade Alerts - baoquankhu1.vn
BLFS SEC FilingsBiolife Solutions Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nasdaq Moves: Whats the profit margin of BioLife Solutions Inc2026 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Aug Mood: Whats the fair value of BioLife Solutions Inc stock2026 WrapUp & AI Driven Price Predictions - baoquankhu1.vn
BioLife Solutions (BLFS) Positioned as a Strategic Investment fo - gurufocus.com
BioLife Solutions (BLFS) CEO uses 11,101 shares for tax withholding - Stock Titan
BioLife Solutions (BLFS) CMO uses shares to cover tax bill - Stock Titan
BIOLIFE SOLUTIONS (BLFS) CTO reports 1,681-share tax withholding on RSU release - Stock Titan
BioLife Solutions (BLFS) CFO has shares withheld to cover RSU taxes - Stock Titan
BioLife Solutions (BLFS) CHRO has 931 shares withheld for RSU taxes - Stock Titan
BioLife Solutions (BLFS) executive has 1,907 shares withheld to cover RSU taxes - Stock Titan
BioLife Solutions (BLFS) EVP has 2,255 shares withheld to cover RSU taxes - Stock Titan
2,577-share sale noted; Karen Foster 10b5-1 trades (BLFS) - Stock Titan
BioLife Solutions, Inc. (BLFS) surpasses Q4 earnings and revenue estimates - MSN
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
BioLife Solutions outlines 17–20% revenue growth target for 2026 while expanding commercial customer mix - MSN
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade - MSN
Is BioLife Solutions Inc. a cyclical or defensive stockMarket Growth Review & Daily Volume Surge Trade Alerts - Mfd.ru
BioLife Solutions, Inc. $BLFS Shares Sold by Granahan Investment Management LLC - MarketBeat
BioLife Solutions, Inc. $BLFS Shares Sold by Fred Alger Management LLC - MarketBeat
BioLife Solutions Earnings Call Signals Profitable Growth - TipRanks
BioLife Solutions, Inc. $BLFS is Casdin Capital LLC's 2nd Largest Position - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
Bothell WA Bio Co. Poised for 17-20% Revenue Growth in 2026 as Cell Therapy Market Expands - Streetwise Reports
BLFSBiolife Solutions Inc Latest Stock News & Market Updates - Stock Titan
After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS) - Yahoo Finance
After a 17.6% Drop Over the Past Four Weeks, Here’s What Could Cause BioLife Solutions (BLFS) to Rebound - Bitget
BioLife Solutions (NASDAQ:BLFS) Hits New 1-Year Low on Insider Selling - MarketBeat
Insider Sell: Karen Foster Sells 97,423 Shares of BioLife Soluti - GuruFocus
Karen Foster Sells 96,923 Shares of BioLife Solutions (NASDAQ:BLFS) Stock - MarketBeat
BioLife Solutions Officer Sells Shares - TradingView
BioLife Solutions (NASDAQ: BLFS) officer sells 97K shares in open market - Stock Titan
Insider sells 500 shares at BioLife Solutions (NASDAQ: BLFS) amid recent 10b5-1 trades - Stock Titan
Volatility Watch: What is C4 Therapeutics Incs valuation compared to sector2026 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
BioLife Solutions, Inc. $BLFS Shares Purchased by Vanguard Group Inc. - MarketBeat
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know - MSN
BioLife Solutions Hits Day High with Strong 7.65% Intraday Surge - Markets Mojo
Cramer Rosenthal Mcglynn LLC Decreases Stock Position in BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions (NASDAQ:BLFS) EVP Aby Mathew Sells 529 Shares - MarketBeat
Troy Wichterman Sells 588 Shares of BioLife Solutions (NASDAQ:BLFS) Stock - MarketBeat
BioLife Solutions (BLFS) EVP sells 529 shares via 10b5-1 tax plan - Stock Titan
Biolife Solutions Inc Azioni (BLFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):